Has Matthew Ramsey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,680,859 in general payments to Matthew Ramsey, MD across 195 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Ramsey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Ramsey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Ramsey, MD

Orthopaedic Surgery · King Of Prussia, PANPI 1376571877

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,548,147 of the $1,680,859 with a category attached, or 92.1%. 13 manufacturers reported payments, led by Smith+Nephew at 58.9% of the total. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,680,859in general payments, 2019–2025

Across 195 payments — averaging $8619.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$990K
Integra Lifesciences Corporation$540K
Zimmer Biomet$143K
Arthrex$5K
Shoulder Innovations, Inc.$2K
Paladin Technology Solutions$1K
plus $815 from 7 others

$117,476in research payments, 2019–2025

Across 30 payments — averaging $3915.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Smith+Nephew$111K
Zimmer Biomet$6K

What the payments were for

Royalty or licence$1,548,14792%
Consulting fees$70,1104%
Speaking & faculty fees$50,0773%
Travel & lodging$7,9780%
Food & beverage$4,5070%
Gifts$390%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	112	$989,688
Integra Lifesciences Corporation	45	$540,053
Zimmer Biomet	10	$142,616
Arthrex	6	$4,783
Shoulder Innovations, Inc.	3	$1,532
Paladin Technology Solutions	10	$1,372
Ascension Orthopedics, Inc.	1	$500
Liberty Surgical Inc.	1	$121
Encore Medical, LP	2	$72
Stryker	2	$69
Bioventus LLC	1	$23
Catalyst Orthoscience	1	$16
Johnson & Johnson	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TSSM - TOTAL SHOULDER SYSTEM METAL$449,277
AETOS Shoulder System$430,565
TITAN$416,265
REVERSE SHOULDER$414,798
Nexel Elbow$142,570
RSS$101,681
TITAN REVERSE SHOULDER SYSTEM$57,709
TITAN-SHOULDER$27,413
FREEDOM WRIST$27,309
External Fixation System$25,309
Bioinductive Implant with Arthroscopic Delivery System - Medium$18,631
TWINFIX$17,966
CUSA CLARITY$6,661
DURASEAL EXACT$6,661
CODMAN HAKIM PRECISION VALVE$6,661
CODMAN CERTAS$6,661
POLAR3$4,250
TSS$2,000
Cadence$2,000
MCP$2,000

How this compares

$1,680,859 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$374,665

Medicare patients

612

Services billed

3,114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketorolac Tromethamine	37	$440
Oxycodone Hcl	123	$290
Meloxicam	75	$120
Amoxicillin	49	$89
Clindamycin Hcl	31	$57
Tramadol Hcl	15	$14

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in King Of Prussia

Peter SharkeyKing Of Prussia$5.7M
William HozackBensalem$10.6M
Jess LonnerBryn Mawr$7.8M
Gerald WilliamsBryn Mawr$6.8M
Mark LazarusBensalem$6.4M
John FenlinPhiladelphia$5.9M
Alexander VaccaroPhiladelphia$4.5M
Selene ParekhBensalem$4.5M
Joseph AbboudPhiladelphia$3.9M
Jonathan GarinoMalvern$3.8M

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →